A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index
NCT ID: NCT01823731
Last Updated: 2013-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2013-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
NCT01538498
A Cohort Establishment Study of Total Management of Ovarian Cancer
NCT06018935
An INternational Frontline Ovarian Cancer Real World Management Study
NCT04460768
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer
NCT05827523
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
NCT01611766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Digital photography \& Checking PCI (tumor size\& location )
* Postoperative surveillance(tumor marker, image and physical examination)
* Developing the best fitting NCC-PCI template to reflect recurrence and survival pattern
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Available preoperative image study (CT and/or MRI and/or PET)
* Patients who gave a written informed consent
* Patients must be surgical candidate considering medical and psychological condition
Exclusion Criteria
20 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang-Yoon Park
Chief, Center for Uterine Cancer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCCNCS-13-700
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.